CFMs reduce viabilities of the NB cells.

<p>Cells were treated with vehicle (Untreated Control), indicated doses of ADR, CFM-1, CFM-4, or CFM-5, 12 h (A) or 24 h (B, C, E). Determination of viable/live cells was carried out by MTT assay. In panel D, NB cells were treated with indicated dose and time of CFM-4 or CFM-5, labeled with propidium iodide, and sorted by flow cytometry. The table represents % cell numbers in respective cell cycle phase. The data in the histograms represent means of three independent experiments; bars, S.E. @, #, * and &, p = <0.05 relative to respective untreated Controls.